Literature DB >> 16517082

Location and characterization of the O-GlcNAcase active site.

Clifford Toleman1, Andrew J Paterson, Jeffrey E Kudlow.   

Abstract

NCOAT is a bifunctional nucleo-cytoplasmic protein with both O-GlcNAcase and histone acetyltransferase domains. The O-GlcNAcase domain catalyzes the removal of O-linked GlcNAc modifications from proteins and we have found that it resides in the N-terminal third of NCOAT. The recognition of the substrate GlcNAc suggests that the O-GlcNAcase is related in structure and catalytic mechanism to chitinases, hexosaminidases and hyaluronidases. These families of glycosidases all possess a catalytic doublet of carboxylate-containing residues, with one providing an acid-base function, and the second acting to orient and use the N-acetyl group of GlcNAc during catalysis. Indeed, we show that the O-GlcNAcase also possesses the catalytic doublet motif shared among these enzymes and that these two essential residues are aspartic acids at positions 175 and 177, respectively, in mouse NCOAT. In addition, a conserved cysteine at 166 and a conserved aspartic acid at 174 were also found to be necessary for fully efficient enzymatic activity. Given this information, we propose that the O-GlcNAcase active site resembles those of the above glycosidases which carry out the hydrolysis of GlcNAc linkages in a substrate-assisted acid-base manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517082     DOI: 10.1016/j.bbagen.2006.01.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

Review 2.  Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.

Authors:  Norbert Fülöp; Richard B Marchase; John C Chatham
Journal:  Cardiovasc Res       Date:  2006-07-29       Impact factor: 10.787

3.  O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors.

Authors:  Damon B Bowe; Andrea Sadlonova; Clifford A Toleman; Zdenek Novak; Yong Hu; Ping Huang; Shibani Mukherjee; Timothy Whitsett; Andra R Frost; Andrew J Paterson; Jeffrey E Kudlow
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

Review 4.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

5.  Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes.

Authors:  Tracey M Gloster; David J Vocadlo
Journal:  Curr Signal Transduct Ther       Date:  2010-01

6.  OGA inhibition by GlcNAc-selenazoline.

Authors:  Eun Ju Kim; Dona C Love; Etzer Darout; Mohannad Abdo; Brian Rempel; Stephen G Withers; Paul R Rablen; John A Hanover; Spencer Knapp
Journal:  Bioorg Med Chem       Date:  2010-08-11       Impact factor: 3.641

7.  Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent.

Authors:  Luyun Zou; Xiaoyuan Zhu-Mauldin; Richard B Marchase; Andrew J Paterson; Jian Liu; Qinglin Yang; John C Chatham
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 8.  The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine.

Authors:  John A Hanover; Michael W Krause; Dona C Love
Journal:  Biochim Biophys Acta       Date:  2009-07-30

Review 9.  Molecular Interrogation to Crack the Case of O-GlcNAc.

Authors:  Arielis Estevez; Dongsheng Zhu; Connor Blankenship; Jiaoyang Jiang
Journal:  Chemistry       Date:  2020-07-20       Impact factor: 5.236

10.  Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.

Authors:  Boglarka Laczy; Bradford G Hill; Kai Wang; Andrew J Paterson; C Roger White; Dongqi Xing; Yiu-Fai Chen; Victor Darley-Usmar; Suzanne Oparil; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-21       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.